Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging

Author(s): Gunter Almer, Harald Mangge, Andreas Zimmer, Ruth Prassl

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 31 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


The integration of lipoprotein-related or apolipoprotein-targeted nanoparticles as pharmaceutical carriers opens new therapeutic and diagnostic avenues in nanomedicine. The concept is to exploit the intrinsic characteristics of lipoprotein particles as being the natural transporter of apolar lipids and fat in human circulation. Discrete lipoprotein assemblies and lipoprotein-based biomimetics offer a versatile nanoparticle platform that can be manipulated and tuned for specific medical applications. This article reviews the possibilities for constructing drug loaded, reconstituted or artificial lipoprotein particles. The advantages and limitations of lipoproteinbased delivery systems are critically evaluated and potential future challenges, especially concerning targeting specificity, concepts for lipoprotein rerouting and design of innovative lipoprotein mimetic particles using apolipoprotein sequences as targeting moieties are discussed. Finally, the review highlights potential medical applications for lipoprotein-based nanoparticle systems in the fields of cardiovascular research, cancer therapy, gene delivery and brain targeting focusing on representative examples from literature.

Keywords: Apolipoproteins, artificial lipoproteins, high density lipoproteins, lipoprotein related nanoparticles, low density lipoproteins, recombinant lipoproteins, reconstituted lipoproteins, synthetic lipoproteins.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 28 October, 2015
Page: [3631 - 3651]
Pages: 21
DOI: 10.2174/0929867322666150716114625

Article Metrics

PDF: 89